Related references
Note: Only part of the references are listed.Design, analysis, power, and sample size calculation for three-phase interrupted time series analysis in evaluation of health policy interventions
Bo Zhang et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2020)
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E. Dorman et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Strengthening the reporting of empirical simulation studies: Introducing the STRESS guidelines
Thomas Monks et al.
JOURNAL OF SIMULATION (2019)
A novel drug management system in the Febuxostat versus Allopurinol Streamlined Trial: A description of a pharmacy system designed to supply medications directly to patients within a prospective multicenter randomised clinical trial
Amy Rogers et al.
CLINICAL TRIALS (2016)
Procurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved?
Bolajoko Jatau et al.
PLOS ONE (2015)
Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Robert B. Penfold et al.
Academic Pediatrics (2013)
Simulation-based power calculation for designing interrupted time series analyses of health policy interventions
Fang Zhang et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Cote d'Ivoire
Armelle Pasquet et al.
PLOS ONE (2010)
Improving investigational drug service operations through development of an innovative computer system
Burgunda V. Sweet et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Share Paper
